Gastroesophageal Junction Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2014-05-07
  Clinical Trial Update: Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma [Phase 2]

  This Phase 2 trial evaluated trebananib (AMG 386) in combination with cisplatin and capecitabine for metastatic gastric, gastroesophageal ju…

• CLINICAL_TRIALS trial_result · 2013-10-08
  Clinical Trial Update: 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction [Phase 2]

  This update reports the completion of a Phase 2 trial evaluating 3-AP (Triapine) plus cisplatin in patients with recurrent or metastatic ade…

• CLINICAL_TRIALS trial_result · 2013-09-30
  Clinical Trial Update: Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery [Phase 1]

  Phase 1 trial evaluating MK-2206 (AKT inhibitor) with lapatinib and trastuzumab in unresectable locally advanced or metastatic HER2-positive…

• CLINICAL_TRIALS trial_result · 2013-08-07
  Clinical Trial Update: Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer [Phase 3]

  A Phase 3 trial evaluated symptom control with docetaxel versus no docetaxel in relapsed esophageal cancer or gastric/gastroesophageal junct…

• CLINICAL_TRIALS trial_result · 2013-06-21
  Clinical Trial Update: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas [Phase 1]

  Phase 1 study of the BMS-833923 investigational agent in combination with cisplatin and capecitabine in patients with inoperable, metastatic…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-11-09
  Clinical Trial Update: Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment [Phase 2]

  Phase 2 trial evaluating the combination of oxaliplatin and sorafenib for advanced or metastatic gastric cancer or gastroesophageal junction…

• CLINICAL_TRIALS trial_result · 2012-02-14
  Clinical Trial Update: Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma [Phase 2]

  This clinical trial update reports on a Phase 2 study of bortezomib for unresectable or metastatic gastric cancer or gastroesophageal juncti…